March 30, 2017 / 1:37 PM / 6 months ago

BRIEF-Alzinova awarded EU funding

March 30 (Reuters) - ALZINOVA AB:

* THE EUROPEAN COMMISSION HAS DECIDED TO AWARD ALZINOVA‘S PROJECT “NOVEL IMMUNOTHERAPEUTIC VACCINE FOR THE TREATMENT OF ALZHEIMER‘S DISEASE (IMMOVA)” FUNDING UNDER PROGRAM HORIZON 2020 SME INSTRUMENT, STEP 1

* FUNDING AMOUNTS TO 50,000 EUROS

Source text: bit.ly/2njFR7z

Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below